Citation Impact
Citing Papers
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
2009
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
2012
Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma
2005
Pten Deficiency Activates Distinct Downstream Signaling Pathways in a Tissue-Specific Manner
2006
Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells
2006
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
2011 Science
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
2010
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma
2007
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
2009
Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
2006
TOR Signaling in Growth and Metabolism
2006 Standout
Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells
2005
WGCNA: an R package for weighted correlation network analysis
2008 Standout
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
2010
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
2008
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity
2012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
High-Grade Glioma Formation Results from Postnatal Pten Loss or Mutant Epidermal Growth Factor Receptor Expression in a Transgenic Mouse Glioma Model
2006
Whole Genome Amplification for Array Comparative Genomic Hybridization Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Histological Sections
2009
Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma
2012
Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells
2008 StandoutNobel
IDH1andIDH2Mutations in Gliomas
2009 Standout
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Genetic Pathways to Primary and Secondary Glioblastoma
2007
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
2015
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Reduced Expression of PTEN Protein and Its Prognostic Implications in Invasive Ductal Carcinoma of the Breast
2005
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases
2008
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
2007
AI in health and medicine
2022 Standout
Paradoxical Relationship Between the Degree of EGFR Amplification and Outcome in Glioblastomas
2012
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
2008 Standout
Factors influencing survival in high-grade gliomas
2003
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
2009
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
2006
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Genetic alterations and signaling pathways in the evolution of gliomas
2009
Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas
2005
Mechanisms of Disease: genetic predictors of response to treatment in brain tumors
2007
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
2005
Recent advances in the molecular genetics of primary gliomas
2003
The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma
2011
Targeted Molecular Therapy of GBM
2003
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
2008 Standout
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance
2004
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice
2007
PIK3CA alterations in primary (de novo) and secondary glioblastomas
2007
Anti‐O6‐Methylguanine‐Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker*
2008
Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma
2005
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis
2020
Neuroblastoma
2007 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Primary brain tumours in adults
2012 Standout
A Network Model of a Cooperative Genetic Landscape in Brain Tumors
2009
Survey of treatment recommendations for anaplastic oligodendroglioma
2007
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
2008 Standout
Identification of molecular subtypes of glioblastoma by gene expression profiling
2003
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
The PI3K Pathway in Human Disease
2017 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
2014
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
2010
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Molecular Epidemiology of Primary Brain Tumors
2009
Long-term survival with glioblastoma multiforme
2007
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
2008
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis
2004
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
2002
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 Standout
PPM1D is a potential target for 17q gain in neuroblastoma.
2003
Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
2003
Pten signaling in gliomas
2002
1p/19q testing has no significance in the workup of glioblastomas
2013
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Molecular Predictors in Glioblastoma
2008
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
2006
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
2004
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
2008
Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
2013
Induction of CD8+T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
2010
Epigenome scans and cancer genome sequencing converge on WNK2 , a kinase-independent suppressor of cell growth
2007
Array Comparative Genomic Hybridization Identifies Genetic Subgroups in Grade 4 Human Astrocytoma
2005
Tumor Cell Autophagy as an Adaptive Response Mediating Resistance to Treatments Such as Antiangiogenic Therapy
2012
Genetic and signaling pathway alterations in glioblastoma relevance to novel targeted therapies
2003
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years
2005
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
2005
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline
2010 StandoutNobel
Genetic Pathways to Glioblastoma
2004
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients
2005
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
2003
Serum IgE, Tumor Epidermal Growth Factor Receptor Expression, and Inherited Polymorphisms Associated with Glioma Survival
2006
Lessons learned in the development of targeted therapy for malignant gliomas
2007
Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma
2013
Putting the Rap on Akt
2004
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity
2009
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
2005
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Works of Sandra Passe being referenced
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2006
MGMT Immunohistochemical Expression and Promoter Methylation in Human Glioblastoma
2008
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors
2005
PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme
2001
Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction Assay
2001
Small Cell Architecture—A Histological Equivalent of EGFR Amplification in Glioblastoma Multiforme?
2001
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas
2004
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
2002
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
2002
YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma
2005